No insider purchase over the last 90 days. The latest, by 박정웅, was filed 31 Jul 2026.
Sanigen Co. Ltd: what insiders have been doing
Sanigen Co. Ltd, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). From 22 October 2025 to 22 October 2026, the disclosure feed for Sanigen Co. Ltd logged 14 filings by 6 insiders.
Purchases and sales both appear in the filings: 9 purchases (2 insiders) and 3 sales (3 insiders). No amount is published for 12 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Among those who bought: 1 major shareholder and 1 chief executive.
For context, the typical company on the same exchange (median of 2,650 companies) published 7 filings over the same period, against 14 filings here. The full history, which starts in 2023, counts 11 purchases against 10 sales.
The latest purchase dates back some time: it was published 101 days ago, on 31 July 2026. Between a trade and the moment it shows up on DART (FSS), the median delay is 3 days. The shorter that gap, the sooner other investors can see what insiders have done.
For comparison within the same sector, see the insider buying recorded at UCB. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- -1.2%Entry ₩2,075 · Close 21 Oct 2026 ₩2,050
- -5.4%Entry ₩1,598 · Close at T+90 ₩1,512
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- 8,700 sharesShareKRXDART:20260731000313Canonical exit: 29 Oct 2026 (T+90)
- 637,845 sharesShareKRXDART:20260710000087Canonical exit: 8 Oct 2026 (T+90)
- 645,382 sharesKRXDART:20260710000081Canonical exit: 8 Oct 2026 (T+90)
- 21,300 sharesShareKRXDART:20260625000073Canonical exit: 23 Sept 2026 (T+90)
- 4,700 sharesKRXDART:20260609000098
- 7,861,487 sharesKRXDART:20260520000224Canonical exit: 11 Aug 2026 (T+90)
- 6,035,003 sharesShareKRXDART:20260520000162Canonical exit: 18 Aug 2026 (T+90)
- 0KRXDART:20260514000842
- 61,507 sharesKRXDART:20260410001198
- 16,000 sharesShareKRXDART:20260319000257
- 11,550 sharesKRXDART:20260319000258Canonical exit: 15 Jun 2026 (T+90)
- ●Executives0DART
- 45,801 sharesKRXDART:20260116000051Canonical exit: 12 Apr 2026 (T+90)
- 55,801 sharesShareKRXDART:20260116000033Canonical exit: 16 Apr 2026 (T+90)
- 23,000 sharesKRXDART:20250901000392
- 36,000 sharesShareKRXDART:20241122000520Canonical exit: 20 Feb 2025 (T+90)
- 36,000 sharesKRXDART:20241122000527Canonical exit: 13 Feb 2025 (T+90)
- 30,946 sharesKRXDART:20240530001028
- ShareKRXDART:20231117000024
- 30,946 sharesKRXDART:20231110000327
- ShareKRXDART:20231110000413
- 30,946 sharesKRXDART:20231109000341
- 30,946 sharesKRXDART:20231108000394
- 30,946 sharesKRXDART:20231106000338
25 of 28 declarations
About Sanigen Co. Ltd
세니젠 is a healthcare and pharmaceutical company listed on the XKRX. It specializes in developing innovative solutions for disease treatment.
